ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Book For Survivors, Other New Publications

August 23, 1991

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994